Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015 (2015), Article ID 412149, 12 pages
http://dx.doi.org/10.1155/2015/412149
Research Article

Sulforaphane Reverses the Expression of Various Tumor Suppressor Genes by Targeting DNMT3B and HDAC1 in Human Cervical Cancer Cells

1Department of Natural Science and Public Health, College of Sustainability Sciences & Humanities, Zayed University, P.O. Box 19282, Dubai, UAE
2School of Life Sciences, Manipal University, P.O. Box 345050, Dubai, UAE
3Department of Microbiology & Immunology, Faculty of Medicine and Health Sciences, United Arab Emirates University, P.O. Box 17666, Al Ain, UAE

Received 22 March 2015; Revised 14 May 2015; Accepted 26 May 2015

Academic Editor: Kuzhuvelil B. Harikumar

Copyright © 2015 Munawwar Ali Khan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. S. You and P. A. Jones, “Cancer genetics and epigenetics: two sides of the same coin?” Cancer Cell, vol. 22, no. 1, pp. 9–20, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Bilke and Y. Gindin, “Evidence for a functional link between chromosomal breakpoints and aberrant DNA methylation in cancer,” Frontiers in Oncology, vol. 4, article 46, Article ID Article 46, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Virani, J. A. Colacino, J. H. Kim, and L. S. Rozek, “Cancer epigenetics: a brief review,” ILAR Journal, vol. 53, no. 3-4, pp. 359–369, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Ivanova, A. Petrenko, T. Gritsko et al., “Methylation and silencing of the retinoic acid receptor-beta 2 gene in cervical cancer,” BMC Cancer, vol. 2, no. 1, article 4, 2002. View at Google Scholar · View at Scopus
  5. J. D. Choi and J. S. Lee, “Interplay between epigenetics and genetics in cancer,” Genomics & Informatics, vol. 11, no. 4, pp. 164–173, 2013. View at Publisher · View at Google Scholar
  6. M. Ghavifekr Fakhr, M. Farshdousti Hagh, D. Shanehbandi, and B. Baradaran, “DNA methylation pattern as important epigenetic criterion in cancer,” Genetics Research International, vol. 2013, Article ID 317569, 9 pages, 2013. View at Publisher · View at Google Scholar
  7. T. O. Tollefsbol, “Dietary epigenetics in cancer and aging,” Cancer treatment and research, vol. 159, pp. 257–267, 2014. View at Google Scholar · View at Scopus
  8. A. Al-Janadi, S. R. Chandana, and B. A. Conley, “Histone deacetylation: an attractive target for cancer therapy?” Drugs in R & D, vol. 9, no. 6, pp. 369–383, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. J. E. Bolden, W. Shi, K. Jankowski et al., “HDAC inhibitors induce tumor-cell-selective pro-apoptotic transcriptional responses,” Cell Death and Disease, vol. 4, no. 2, article e519, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Gnyszka, Z. Jastrzȩbski, and S. Flis, “DNA methyltransferase inhibitors and their emerging role in epigenetic therapy of cancer,” Anticancer Research, vol. 33, no. 8, pp. 2989–2996, 2013. View at Google Scholar · View at Scopus
  11. P. Rajendran, A. I. Kidane, T.-W. Yu et al., “HDAC turnover, CtIP acetylation and dysregulated DNA damage signaling in colon cancer cells treated with sulforaphane and related dietary isothiocyanates,” Epigenetics, vol. 8, no. 6, pp. 612–623, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. Q. Xie, Q. Bai, L. Zou et al., “Genistein inhibits DNA methylation and increases expression of tumor suppressor genes in human breast cancer cells,” Genes, Chromosomes and Cancer, vol. 53, no. 5, pp. 422–431, 2014. View at Publisher · View at Google Scholar
  13. G. P. Nagaraju, S. Zhu, J. Wen et al., “Novel synthetic curcumin analogues EF31 and UBS109 are potent DNA hypomethylating agents in pancreatic cancer,” Cancer Letters, vol. 341, no. 2, pp. 195–203, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Wang, Y. Zhao, and R. Gao, “Resveratrol can reduce the expression of WT1 by methylation in K562 cells,” Zhonghua Xue Ye Xue Za Zhi, vol. 35, no. 3, pp. 245–246, 2014. View at Publisher · View at Google Scholar
  15. V. Nandakumar, M. Vaid, and S. K. Katiyar, “(−)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells,” Carcinogenesis, vol. 32, no. 4, pp. 537–544, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Lenzi, C. Fimognari, and P. Hrelia, “Sulforaphane as a promising molecule for fighting cancer,” Cancer Treatment and Research, vol. 159, pp. 207–223, 2014. View at Google Scholar · View at Scopus
  17. T. W. Kensler, P. A. Egner, A. S. Agyeman et al., “Keap1-Nrf2 signaling: a target for cancer prevention by sulforaphane,” Topics in Current Chemistry, vol. 329, pp. 163–177, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Sharma, L. Sadrieh, A. Priyani, M. Ahmed, A. H. Hassan, and A. Hussain, “Anti-carcinogenic effects of sulforaphane in association with its apoptosis-inducing and anti-inflammatory properties in human cervical cancer cells,” Cancer Epidemiology, vol. 35, no. 3, pp. 272–278, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. F. C. Bernstein, T. F. Koetzle, G. J. Williams et al., “The Protein Data Bank: a computer-based archival file for macromolecular structures,” Journal of Molecular Biology, vol. 112, no. 3, pp. 535–542, 1977. View at Google Scholar
  20. R. Apweiler, A. Bairoch, C. H. Wu et al., “UniProt: the universal protein knowledgebase,” Nucleic Acids Research, vol. 32, pp. D115–D119, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. S. McGinnis and T. L. Madden, “BLAST: at the core of a powerful and diverse set of sequence analysis tools,” Nucleic Acids Research, vol. 32, pp. W20–W25, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. J. C. Bressi, A. J. Jennings, R. Skene et al., “Exploration of the HDAC2 foot pocket: synthesis and SAR of substituted N-(2-aminophenyl)benzamides,” Bioorganic and Medicinal Chemistry Letters, vol. 20, no. 10, pp. 3142–3145, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Arnold, L. Bordoli, J. Kopp, and T. Schwede, “The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling,” Bioinformatics, vol. 22, no. 2, pp. 195–201, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Benkert, M. Biasini, and T. Schwede, “Toward the estimation of the absolute quality of individual protein structure models,” Bioinformatics, vol. 27, no. 3, Article ID btq662, pp. 343–350, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. C. J. Millard, P. J. Watson, I. Celardo et al., “Class I HDACs share a common mechanism of regulation by inositol phosphates,” Molecular Cell, vol. 51, no. 1, pp. 57–67, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Dundas, Z. Ouyang, J. Tseng, A. Binkowski, Y. Turpaz, and J. Liang, “CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues,” Nucleic Acids Research, vol. 34, pp. W116–W118, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Kuck, T. Caulfield, F. Lyko, and J. L. Medina-Franco, “Nanaomycin A selectively inhibits DNMT3B and reactivates silenced tumor suppressor genes in human cancer cells,” Molecular Cancer Therapeutics, vol. 9, no. 11, pp. 3015–3023, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. A. C. Wallace, R. A. Laskowski, and J. M. Thornton, “LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions,” Protein Engineering, vol. 8, no. 2, pp. 127–134, 1995. View at Publisher · View at Google Scholar · View at Scopus
  29. E. Krissinel and K. Henrick, “Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions,” Acta Crystallographica Section D: Biological Crystallography, vol. 60, no. 12, pp. 2256–2268, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Thangapandian, S. John, Y. Lee, V. Arulalapperumal, and K. W. Lee, “Molecular modeling study on tunnel behavior in different histone deacetylase isoforms,” PLoS ONE, vol. 7, no. 11, Article ID e49327, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Schäfer, L. Saunders, E. Eliseeva et al., “Phenylalanine-containing hydroxamic acids as selective inhibitors of class IIb histone deacetylases (HDACs),” Bioorganic & Medicinal Chemistry, vol. 16, no. 4, pp. 2011–2033, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. J. J. Irwin, T. Sterling, M. M. Mysinger, E. S. Bolstad, and R. G. Coleman, “ZINC: A free tool to discover chemistry for biology,” Journal of Chemical Information and Modeling, vol. 52, no. 7, pp. 1757–1768, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Grosdidier, V. Zoete, and O. Michielin, “SwissDock, a protein-small molecule docking web service based on EADock DSS,” Nucleic Acids Research, vol. 39, no. 2, pp. W270–W277, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. E. F. Pettersen, T. D. Goddard, C. C. Huang et al., “UCSF Chimera—a visualization system for exploratory research and analysis,” Journal of Computational Chemistry, vol. 25, no. 13, pp. 1605–1612, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Singal, J. van Wert, and M. Bashambu, “Cytosine methylation represses glutathione S-transferase P1 (GSTP1) gene expression in human prostate cancer cells,” Cancer Research, vol. 61, no. 12, pp. 4820–4826, 2001. View at Google Scholar · View at Scopus
  36. N. H. El-Shakankiry and G. I. Mossallam, “p15 (INK4B) and E-cadherin CpG island methylation is frequent in Egyptian acute myeloid leukemia,” Journal of the Egyptian National Cancer Institute, vol. 18, no. 3, pp. 227–232, 2006. View at Google Scholar · View at Scopus
  37. A. Tserga, N. V. Michalopoulos, G. Levidou et al., “Association of aberrant DNA methylation with clinicopathological features in breast cancer,” Oncology Reports, vol. 27, no. 5, pp. 1630–1638, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Pan, T. Lei, B. Teng et al., “Role of vimentin in the inhibitory effects of low-molecular-weight heparin on PC-3M cell adhesion to, and migration through, endothelium,” The Journal of Pharmacology and Experimental Therapeutics, vol. 339, no. 1, pp. 82–92, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Jin, E. K. Blue, and P. J. Gallagher, “Control of death-associated protein kinase (DAPK) activity by phosphorylation and proteasomal degradation,” The Journal of Biological Chemistry, vol. 281, no. 51, pp. 39033–39040, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. X. Lin, K. Asgari, M. J. Putzi et al., “Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide,” Cancer Research, vol. 61, no. 24, pp. 8611–8616, 2001. View at Google Scholar · View at Scopus
  41. F. Wang, J. Xu, Q. Zhu et al., “Downregulation of IFNG in CD4+ T cells in lung cancer through hypermethylation: a possible mechanism of tumor-induced immunosuppression,” PLoS ONE, vol. 8, no. 11, Article ID e79064, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. A. G. Wang, S. U. Kim, S. H. Lee et al., “Histone deacetylase 1 contributes to cell cycle and apoptosis,” Biological and Pharmaceutical Bulletin, vol. 28, no. 10, pp. 1966–1970, 2005. View at Google Scholar
  43. M. Z. Fang, Y. Wang, N. Ai et al., “Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines,” Cancer Research, vol. 63, no. 22, pp. 7563–7570, 2003. View at Google Scholar · View at Scopus
  44. M. Z. Fang, D. Chen, Y. Sun, Z. Jin, J. K. Christman, and C. S. Yang, “Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy,” Clinical Cancer Research, vol. 11, no. 19, part 1, pp. 7033–7041, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. A. M. Oommen, J. B. Griffin, G. Sarath, and J. Zempleni, “Roles for nutrients in epigenetic events,” Journal of Nutritional Biochemistry, vol. 16, no. 2, pp. 74–77, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. M. C. Myzak, P. Tong, W.-M. Dashwood, R. H. Dashwood, and E. Ho, “Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects,” Experimental Biology and Medicine, vol. 232, no. 2, pp. 227–234, 2007. View at Google Scholar · View at Scopus
  47. A. Pledgie-Tracy, M. D. Sobolewski, and N. E. Davidson, “Sulforaphane induces cell type-specific apoptosis in human breast cancer cell lines,” Molecular Cancer Therapeutics, vol. 6, no. 3, pp. 1013–1021, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. J. D. Clarke, A. Hsu, Z. Yu, R. H. Dashwood, and E. Ho, “Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells,” Molecular Nutrition and Food Research, vol. 55, no. 7, pp. 999–1009, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. R. Schneider-Stock, M. Diab-Assef, A. Rohrbeck et al., “5-Aza-cytidine is a potent inhibitor of DNA methyltransferase 3a and induces apoptosis in HCT-116 colon cancer cells via Gadd45- and p53-dependent mechanisms,” Journal of Pharmacology and Experimental Therapeutics, vol. 312, no. 2, pp. 525–536, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. K. Patel, J. Dickson, S. Din, K. Macleod, D. Jodrell, and B. Ramsahoye, “Targeting of 5-aza-2′-deoxycytidine residues by chromatin-associated DNMT1 induces proteasomal degradation of the free enzyme,” Nucleic Acids Research, vol. 38, no. 13, Article ID gkq187, pp. 4313–4324, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. Y.-B. Ding, C.-L. Long, X.-Q. Liu et al., “5-Aza-2′-deoxycytidine leads to reduced embryo implantation and reduced expression of DNA methyltransferases and essential endometrial genes,” PLoS ONE, vol. 7, no. 9, Article ID e45364, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Hsu, C. P. Wong, Z. Yu, D. E. Williams, R. H. Dashwood, and E. Ho, “Promoter de-methylation of cyclin D2 by sulforaphane in prostate cancer cells,” Clinical Epigenetics, vol. 3, no. 1, article 3, 2011. View at Publisher · View at Google Scholar
  53. Z.-Y. Su, C. Zhang, J. H. Lee et al., “Requirement and epigenetics reprogramming of Nrf2 in suppression of tumor promoter TPA-induced mouse skin cell transformation by sulforaphane,” Cancer Prevention Research, vol. 7, no. 3, pp. 319–329, 2014. View at Publisher · View at Google Scholar · View at Scopus
  54. H. Fan, R. Zhang, D. Tesfaye et al., “Sulforaphane causes a major epigenetic repression of myostatin in porcine satellite cells,” Epigenetics, vol. 7, no. 12, pp. 1379–1390, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. R. H. Dashwood and E. Ho, “Dietary histone deacetylase inhibitors: from cells to mice to man,” Seminars in Cancer Biology, vol. 17, no. 5, pp. 363–369, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. F. Zanichelli, S. Capasso, M. Cipollaro et al., “Dose-dependent effects of R-sulforaphane isothiocyanate on the biology of human mesenchymal stem cells, at dietary amounts, it promotes cell proliferation and reduces senescence and apoptosis, while at anti-cancer drug doses, it has a cytotoxic effect,” Age, vol. 34, no. 2, pp. 281–293, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. A. Sekhavat, J.-M. Sun, and J. R. Davie, “Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate,” Biochemistry and Cell Biology, vol. 85, no. 6, pp. 751–758, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. J. Chang, D. S. Varghese, M. C. Gillam et al., “Differential response of cancer cells to HDAC inhibitors trichostatin A and depsipeptide,” British Journal of Cancer, vol. 106, no. 1, pp. 116–125, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. J. R. Somoza, R. J. Skene, B. A. Katz et al., “Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases,” Structure, vol. 12, no. 7, pp. 1325–1334, 2004. View at Publisher · View at Google Scholar · View at Scopus
  60. G. Narayan, H. Arias-Pulido, S. Koul et al., “Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome,” Molecular Cancer, vol. 2, article 24, 2003. View at Publisher · View at Google Scholar · View at Scopus
  61. Y. Qu, G. Mu, Y. Wu et al., “Overexpression of DNA methyltransferases 1, 3a, and 3b significantly correlates with retinoblastoma tumorigenesis,” American Journal of Clinical Pathology, vol. 134, no. 5, pp. 826–834, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. D. A. Ovchinnikov, M. A. Cooper, P. Pandit et al., “Tumor-suppressor gene promoter hypermethylation in saliva of head and neck cancer patients,” Translational Oncology, vol. 5, no. 5, pp. 321–326, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. L. Alkebsi, H. Handa, Y. Sasaki et al., “DNMT3B7 expression related to MENT expression and its promoter methylation in human lymphomas,” Leukemia Research, vol. 37, no. 12, pp. 1662–1667, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. C. Banzai, K. Nishino, J. Quan et al., “Gynecological Cancer Registry of Niigata. Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A genes in cervical carcinoma,” International Journal of Clinical Oncology, vol. 19, no. 1, pp. 127–132, 2014. View at Publisher · View at Google Scholar · View at Scopus
  65. S. Divyya, S. M. Naushad, P. V. L. N. Murthy, C. R. Reddy, and V. K. Kutala, “GCPII modulates oxidative stress and prostate cancer susceptibility through changes in methylation of RASSF1, BNIP3, GSTP1 and Ec-SOD,” Molecular Biology Reports, vol. 40, no. 10, pp. 5541–5550, 2013. View at Publisher · View at Google Scholar · View at Scopus
  66. R. Fiolka, P. Zubor, V. Janusicova et al., “Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer,” Oncology Reports, vol. 30, no. 6, pp. 2878–2886, 2013. View at Publisher · View at Google Scholar · View at Scopus
  67. T. Miyake, T. Nakayama, N. Kagara et al., “Association of GSTP1 methylation with aggressive phenotype in ER-positive breast cancer,” Anticancer Research, vol. 33, no. 12, pp. 5617–5623, 2013. View at Google Scholar · View at Scopus
  68. G. Pannone, A. Santoro, A. Feola et al., “The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage,” Current Cancer Drug Targets, vol. 14, no. 2, pp. 115–127, 2014. View at Publisher · View at Google Scholar · View at Scopus
  69. Y. Qu, S. Dang, and P. Hou, “Gene methylation in gastric cancer,” Clinica Chimica Acta, vol. 424, pp. 53–65, 2013. View at Publisher · View at Google Scholar · View at Scopus
  70. K. Revill, T. Wang, A. Lachenmayer et al., “Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma,” Gastroenterology, vol. 145, no. 6, pp. 1424.e25–1435.e25, 2013. View at Publisher · View at Google Scholar · View at Scopus
  71. C. Moison, F. Assemat, A. Daunay, J. Tost, A.-L. Guieysse-Peugeot, and P. B. Arimondo, “Synergistic chromatin repression of the tumor suppressor gene RARB in human prostate cancers,” Epigenetics, vol. 9, no. 4, pp. 477–482, 2014. View at Publisher · View at Google Scholar · View at Scopus
  72. A. S. Ho, S. Turcan, and T. A. Chan, “Epigenetic therapy: use of agents targeting deacetylation and methylation in cancer management,” OncoTargets and Therapy, vol. 6, pp. 223–232, 2013. View at Publisher · View at Google Scholar · View at Scopus
  73. C.-C. Wu, H.-Y. Chuang, C.-Y. Lin et al., “Inhibition of epstein-barr virus reactivation in nasopharyngeal carcinoma cells by dietary sulforaphane,” Molecular Carcinogenesis, vol. 52, no. 12, pp. 946–958, 2013. View at Publisher · View at Google Scholar · View at Scopus